126 related articles for article (PubMed ID: 12472567)
1. Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma.
Zhu Y; Hollmén J; Räty R; Aalto Y; Nagy B; Elonen E; Kere J; Mannila H; Franssila K; Knuutila S
Br J Haematol; 2002 Dec; 119(4):905-15. PubMed ID: 12472567
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV.
de Vos S; Krug U; Hofmann WK; Pinkus GS; Swerdlow SH; Wachsman W; Grogan TM; Said JW; Koeffler HP
Diagn Mol Pathol; 2003 Mar; 12(1):35-43. PubMed ID: 12605034
[TBL] [Abstract][Full Text] [Related]
3. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CI; Sander B
Leukemia; 2003 Sep; 17(9):1880-90. PubMed ID: 12970790
[TBL] [Abstract][Full Text] [Related]
4. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
[TBL] [Abstract][Full Text] [Related]
5. Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma.
Yin CC; Medeiros LJ; Cromwell CC; Mehta AP; Lin P; Luthra R; Abruzzo LV
Mod Pathol; 2007 Jan; 20(1):1-7. PubMed ID: 17057651
[TBL] [Abstract][Full Text] [Related]
6. Mantle cell lymphoma, blastoid variant, diagnosed on the basis of cytomorphology and flow cytometric immunophenotyping of the lymph node aspirate and peripheral blood.
Lee MJ; Kee KH; Jeon HJ
J Korean Med Sci; 2002 Apr; 17(2):173-8. PubMed ID: 11961299
[TBL] [Abstract][Full Text] [Related]
7. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
Morice WG; Hodnefield JM; Kurtin PJ; Hanson CA
Am J Clin Pathol; 2004 Jul; 122(1):122-7. PubMed ID: 15272540
[TBL] [Abstract][Full Text] [Related]
8. Blastic transformation of mantle cell lymphoma: genetic evidence for a clonal link between the two stages of the tumour.
László T; Matolcsy A
Histopathology; 1999 Oct; 35(4):355-9. PubMed ID: 10564390
[TBL] [Abstract][Full Text] [Related]
9. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic variations in mantle cell lymphoma.
Gao J; Peterson L; Nelson B; Goolsby C; Chen YH
Am J Clin Pathol; 2009 Nov; 132(5):699-706. PubMed ID: 19846810
[TBL] [Abstract][Full Text] [Related]
11. Expression of centrosome-associated gene products is linked to tetraploidization in mantle cell lymphoma.
Neben K; Ott G; Schweizer S; Kalla J; Tews B; Katzenberger T; Hahn M; Rosenwald A; Ho AD; Müller-Hermelink HK; Lichter P; Krämer A
Int J Cancer; 2007 Apr; 120(8):1669-77. PubMed ID: 17236200
[TBL] [Abstract][Full Text] [Related]
12. The Wnt signaling pathway and mitotic regulators in the initiation and evolution of mantle cell lymphoma: Gene expression analysis.
Kimura Y; Arakawa F; Kiyasu J; Miyoshi H; Yoshida M; Ichikawa A; Niino D; Sugita Y; Okamura T; Doi A; Yasuda K; Tashiro K; Kuhara S; Ohshima K
Int J Oncol; 2013 Aug; 43(2):457-68. PubMed ID: 23760751
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.
Ripperger T; von Neuhoff N; Kamphues K; Emura M; Lehmann U; Tauscher M; Schraders M; Groenen P; Skawran B; Rudolph C; Callet-Bauchu E; van Krieken JH; Schlegelberger B; Steinemann D
Haematologica; 2007 Apr; 92(4):460-8. PubMed ID: 17488656
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways.
Rizzatti EG; Falcão RP; Panepucci RA; Proto-Siqueira R; Anselmo-Lima WT; Okamoto OK; Zago MA
Br J Haematol; 2005 Aug; 130(4):516-26. PubMed ID: 16098065
[TBL] [Abstract][Full Text] [Related]
15. CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series.
Akhter A; Mahe E; Street L; Pournazari P; Perizzolo M; Shabani-Rad MT; Stewart DA; Mansoor A
J Clin Pathol; 2015 Oct; 68(10):844-8. PubMed ID: 26124315
[TBL] [Abstract][Full Text] [Related]
16. Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes.
Schraders M; Jares P; Bea S; Schoenmakers EF; van Krieken JH; Campo E; Groenen PJ
Br J Haematol; 2008 Oct; 143(2):210-21. PubMed ID: 18699851
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for blastoid transformation in the common variant of mantle cell lymphoma.
Räty R; Franssila K; Jansson SE; Joensuu H; Wartiovaara-Kautto U; Elonen E
Eur J Cancer; 2003 Feb; 39(3):321-9. PubMed ID: 12565984
[TBL] [Abstract][Full Text] [Related]
18. IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome.
Cogliatti SB; Bertoni F; Zimmermann DR; Henz S; Diss TC; Ghielmini M; Schmid U
J Pathol; 2005 Jul; 206(3):320-7. PubMed ID: 15887292
[TBL] [Abstract][Full Text] [Related]
19. The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival.
Martínez N; Camacho FI; Algara P; Rodríguez A; Dopazo A; Ruíz-Ballesteros E; Martín P; Martínez-Climent JA; García-Conde J; Menárguez J; Solano F; Mollejo M; Piris MA
Cancer Res; 2003 Dec; 63(23):8226-32. PubMed ID: 14678979
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome.
Michaux L; Wlodarska I; Theate I; Stul M; Scheiff JM; Deneys V; Ferrant A; Hagemeijer A
Ann Hematol; 2004 Sep; 83(9):578-83. PubMed ID: 15138714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
